pharmaceuticals
pharmaceuticals Articles
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
Published:
Last Updated:
Regeneron Pharmaceuticals is facing some difficulty after it received an update from the FDA on Eylea (aflibercept) Injection in patients with wet age-related macular degeneration.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Mylan reported disappointing quarterly results before the markets opened on Wednesday, and shares retreated afterward.
Published:
Last Updated:
CVS is scheduled to release its second-quarter financial results before the markets open on Wednesday.
Published:
Last Updated:
Whether you are a consumer or an employer, there is a pretty good chance you would like to have lower costs of health care.
Published:
Last Updated:
Teva shares stumbled after it released its most recent quarterly results before the markets opened on Thursday.
Published:
Last Updated:
Pfizer released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Pfizer is scheduled to release its second-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
AbbVie released a better-than-expected quarterly report early on Friday, but shares retreated afterward.
Published:
Last Updated:
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
Published:
Last Updated:
Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good print from Johnson & Johnson as a good signal for the...
Published:
Last Updated:
Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain.
Published:
Last Updated:
Johnson & Johnson reported better-than-expected second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated: